Clascoterone News
Clascoterone currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Clascoterone with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Adults Winlevi is indicated for the treatment of acne vulgaris. Adolescents (from 12 to < 18 years of age) Winlevi is indicated for the treatment of facial acne vulgaris.
- Evidence level: L5
- Predicted indications (20):
- candidiasis (94.8%)
- migraine disorder (92.1%)
- migraine with brainstem aura (91.4%)
- migraine with or without aura, susceptibility to (89.4%)
- leprosy (88.9%)
- atrophoderma vermiculata (86.8%)
- oral candidiasis (86.7%)
- progeria-short stature-pigmented nevi syndrome (86.0%)
- adrenal gland hyperfunction (85.9%)
- multiple endocrine neoplasia (85.5%)
- ulerythema ophryogenesis (85.3%)
- progeroid syndrome, Petty type (85.2%)
- commissural lip fistula (84.9%)
- osteoradionecrosis of the mandible (84.9%)
- burning mouth syndrome (84.8%)
- oral leukoedema (84.8%)
- hyperargininemia (84.8%)
- carbamoyl phosphate synthetase I deficiency disease (84.8%)
- Leydig cell hypoplasia due to LH resistance (82.7%)
- bone marrow neoplasm (82.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.